Browse by author
Lookup NU author(s): Dr Asima Mukhopadhyay
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
Adnexal masses are diagnosed in 5% pregnancies and pose diagnostic and management challenges. Ultrasound and magnetic resonance imaging (MRI) are the mainstay as an evaluation procedure; surgery is warranted for persistent masses with a diameter of >5 cm and sonographic signs of possible malignancy. Optimal timing for a planned surgery is the second trimester and does not adversely affect neonatal outcome. Laparoscopy is safe in pregnancy. Management for ovarian cancer during pregnancy should be individualised and formulated by a multidisciplinary team in a specialised centre while also considering the patients' wishes to preserve pregnancy. The following options can be considered: (i) induced abortion followed by standard management of ovarian cancer, (ii) pregnancy-preserving surgery followed by chemotherapy, planned delivery and secondary surgical completion or (iii) neoadjuvant chemotherapy followed by surgery during the postpartum period. Standard chemotherapy administered in nonpregnant population can only be used during the first trimester of pregnancy. (C) 2015 Elsevier Ltd. All rights reserved.
Author(s): Mukhopadhyay A, Shinde A, Naik R
Publication type: Article
Publication status: Published
Journal: Best Practice & Research Clinical Obstetrics & Gynaecology
Year: 2016
Volume: 33
Pages: 58-72
Print publication date: 01/05/2016
Online publication date: 30/10/2015
Acceptance date: 01/01/1900
ISSN (print): 1521-6934
ISSN (electronic): 1532-1932
Publisher: Elsevier
URL: http://dx.doi.org/10.1016/j.bpobgyn.2015.10.015
DOI: 10.1016/j.bpobgyn.2015.10.015
Altmetrics provided by Altmetric